Targeting splenic hematopoietic stem cells in cardiovascular disease
Targeting splenic hematopoietic stem cells in cardiovascular disease |
https://doi.org/10.18632/oncotarget.4918
Matthias Nahrendorf,
and Partha Dutta
|
19918-19919 |
The host cell side of latent HIV-1 infection
The host cell side of latent HIV-1 infection |
https://doi.org/10.18632/oncotarget.5101
Lillian Seu,
and Olaf Kutsch
|
19920-19921 |
Platelet signaling - blood’s great balancing act
Platelet signaling - blood’s great balancing act |
https://doi.org/10.18632/oncotarget.5122
Wolfgang Bergmeier,
and Lucia Stefanini
|
19922-19923 |
Gamma-carboxylation regulates osteocalcin function
Gamma-carboxylation regulates osteocalcin function |
https://doi.org/10.18632/oncotarget.5126
Julie Lacombe,
and Mathieu Ferron
|
19924-19925 |
Arcuate nucleus glucokinase and dietary glucose intake
Arcuate nucleus glucokinase and dietary glucose intake |
https://doi.org/10.18632/oncotarget.5138
Yue Ma,
Steve R. Bloom,
and James V. Gardiner
|
19926-19927 |
A new “sweet” ligand for Toll-like receptor 4
A new “sweet” ligand for Toll-like receptor 4 |
https://doi.org/10.18632/oncotarget.4562
Tomas Deierborg,
and Miguel A. Burguillos
|
19928-19929 |
Deciphering the biology of NKG2C+ Natural Killer cells
Deciphering the biology of NKG2C+ Natural Killer cells |
https://doi.org/10.18632/oncotarget.4468
Alexander Rölle
|
19930-19931 |
NK cells in asthma exacerbation
NK cells in asthma exacerbation |
https://doi.org/10.18632/oncotarget.4841
Lars Lunding,
and Michael Wegmann
|
19932-19933 |
Immunodeficiency and CARD-BCL10-MALT1
Immunodeficiency and CARD-BCL10-MALT1 |
https://doi.org/10.18632/oncotarget.4467
Rebeca Pérez de Diego
|
19934-19935 |
GP96: safeguarding Treg |
https://doi.org/10.18632/oncotarget.4582
Yongliang Zhang,
Ephraim Ansa-Addo,
and Zihai Li
|
19936-19937 |
The ‘inflammatory’ control of hematopoietic stem cells
The ‘inflammatory’ control of hematopoietic stem cells |
https://doi.org/10.18632/oncotarget.4591
Chozha V. Rathinam
|
19938-19939 |
dsRNA in immunometabolism
dsRNA in immunometabolism |
https://doi.org/10.18632/oncotarget.5100
Takahisa Nakamura
|
19940-19941 |
Notch, metabolism and macrophages
Notch, metabolism and macrophages |
https://doi.org/10.18632/oncotarget.4651
Jun Xu,
Feng Chi,
and Hidekazu Tsukamoto
|
19942-19943 |
Basal body docking in airway ciliated cells
Basal body docking in airway ciliated cells |
https://doi.org/10.18632/oncotarget.4609
Feng-Qian Li,
Saul S. Siller,
and Ken-Ichi Takemaru
|
19944-19945 |
CX3CR1 in multiple sclerosis
CX3CR1 in multiple sclerosis |
https://doi.org/10.18632/oncotarget.4650
Serge Rivest
|
19946-19947 |
BTK: sensing pathogenic nucleic acids
BTK: sensing pathogenic nucleic acids |
https://doi.org/10.18632/oncotarget.4778
Koon-Guan Lee,
and Kong-Peng Lam
|
19948-19949 |
NLRP12 in autoimmune diseases
NLRP12 in autoimmune diseases |
https://doi.org/10.18632/oncotarget.4585
Prajwal Gurung,
and Thirumala-Devi Kanneganti
|
19950-19951 |
Sox5 and Th17 cell differentiation
Sox5 and Th17 cell differentiation |
https://doi.org/10.18632/oncotarget.4784
Akira Suto,
Shigeru Tanaka,
and Hiroshi Nakajima
|
19952-19953 |
Sec61 in antigen cross-presentation
Sec61 in antigen cross-presentation |
https://doi.org/10.18632/oncotarget.4587
Matthias Zehner,
and Sven Burgdorf
|
19954-19955 |
Treg: tolerance vs immunity
Treg: tolerance vs immunity |
https://doi.org/10.18632/oncotarget.4648
Moanaro Biswas,
Cox Terhorst,
and Roland W. Herzog
|
19956-19957 |
Effector Tregs: middle-men in TGFβ activation
Effector Tregs: middle-men in TGFβ activation |
https://doi.org/10.18632/oncotarget.4686
John J. Worthington,
and Mark A. Travis
|
19958-19959 |
IFN type III: in vivo NK cell response
IFN type III: in vivo NK cell response |
https://doi.org/10.18632/oncotarget.4758
Fernando Souza-Fonseca-Guimaraes,
Arabella Young,
and Mark J. Smyth
|
19960-19961 |
Microbial control of intestinal innate immunity
Microbial control of intestinal innate immunity |
https://doi.org/10.18632/oncotarget.4780
Martina Brave,
Dana J. Lukin,
and Sridhar Mani
|
19962-19963 |
iCD8α cells: living at the edge of the intestinal immune system
iCD8α cells: living at the edge of the intestinal immune system |
https://doi.org/10.18632/oncotarget.4782
Danyvid Olivares-Villagómez,
and Luc Van Kaer
|
19964-19965 |
Self-control for IgE production
Self-control for IgE production |
https://doi.org/10.18632/oncotarget.4806
Brice Laffleur,
and Michel Cogné
|
19966-19967 |
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors |
https://doi.org/10.18632/oncotarget.4847
Peixin Dong,
Kei Ihira,
Junichi Hamada,
Hidemichi Watari,
Takahiro Yamada,
Masayoshi Hosaka,
Sharon J.B. Hanley,
Masataka Kudo,
and Noriaki Sakuragi
|
19968-19975 |
Going viral: a review of replication-selective oncolytic adenoviruses
Going viral: a review of replication-selective oncolytic adenoviruses |
https://doi.org/10.18632/oncotarget.5116
Christopher Larson,
Bryan Oronsky,
Jan Scicinski,
Gary R. Fanger,
Meaghan Stirn,
Arnold Oronsky,
and Tony R. Reid
|
19976-19989 |
Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway
Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway |
https://doi.org/10.18632/oncotarget.4598
Takushi Namba,
Kiki Chu,
Rika Kodama,
Sanguine Byun,
Kyoung Wan Yoon,
Masatsugu Hiraki,
Anna Mandinova,
and Sam W. Lee
|
19990-20001 |
Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation
Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation |
https://doi.org/10.18632/oncotarget.4755
Han-Ching Tseng,
Keiichi Kanayama,
Kawaljit Kaur,
So-Hyun Park,
Sil Park,
Anna Kozlowska,
Shuting Sun,
Charles E. McKenna,
Ichiro Nishimura,
and Anahid Jewett
|
20002-20025 |
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP |
https://doi.org/10.18632/oncotarget.4771
Eyad Elkord,
May Abd Al Samid,
and Belal Chaudhary
|
20026-20036 |
A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation
A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation |
https://doi.org/10.18632/oncotarget.5042
Judith Wienke,
Willemijn Janssen,
Rianne Scholman,
Hilde Spits,
Marielle van Gijn,
Marianne Boes,
Joris van Montfrans,
Nicolette Moes,
and Sytze de Roock
|
20037-20042 |
Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6
Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6 |
https://doi.org/10.18632/oncotarget.4994
Karin M. E. Andersson,
Mikael Brisslert,
Nicola Filluelo Cavallini,
Mattias N. D. Svensson,
Amanda Welin,
Malin C. Erlandsson,
Michael J. Ciesielski,
Gergely Katona,
and Maria I. Bokarewa
|
20043-20057 |
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis |
https://doi.org/10.18632/oncotarget.2780
Marco Scarpa,
Paola Brun,
Melania Scarpa,
Susan Morgan,
Andrea Porzionato,
Andromachi Kotsafti,
Marina Bortolami,
Andrea Buda,
Renata D’Incà,
Veronica Macchi,
Giacomo C. Sturniolo,
Massimo Rugge,
Romeo Bardini,
Ignazio Castagliuolo,
Imerio Angriman,
and Carlo Castoro
|
20058-20069 |
MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer |
https://doi.org/10.18632/oncotarget.4039
Xiaoping Liu,
Hailin Tang,
Jianping Chen,
Cailu Song,
Lu Yang,
Peng Liu,
Neng Wang,
Xinhua Xie,
Xiaoti Lin,
and Xiaoming Xie
|
20070-20083 |
A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence
A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence |
https://doi.org/10.18632/oncotarget.3907
Ju-Yi Hsieh,
Shao-Yu Li,
Wen-Chen Tsai,
Jyung-Hurng Liu,
Chih-Li Lin,
Guang-Yaw Liu,
and Hui-Chih Hung
|
20084-20098 |
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Clinical next generation sequencing to identify actionable aberrations in a phase I program |
https://doi.org/10.18632/oncotarget.4040
Genevieve M. Boland,
Sarina A. Piha-Paul,
Vivek Subbiah,
Mark Routbort,
Shelley M. Herbrich,
Keith Baggerly,
Keyur P. Patel,
Lauren Brusco,
Chacha Horombe,
Aung Naing,
Siqing Fu,
David S. Hong,
Filip Janku,
Amber Johnson,
Russell Broaddus,
Raja Luthra,
Kenna Shaw,
John Mendelsohn,
Gordon B. Mills,
and Funda Meric-Bernstam
|
20099-20110 |
Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer
Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.3933
Zhong-Liang Ma,
Bing-Jie Zhang,
De-Tao Wang,
Xue Li,
Jia-Li Wei,
Bo-Tao Zhao,
Yan Jin,
Yan-Li Li,
and You-Xin Jin
|
20111-20120 |
A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells
A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells |
https://doi.org/10.18632/oncotarget.4041
Jing Yu,
Shaowei Qiu,
Qiufu Ge,
Ying Wang,
Hui Wei,
Dianwu Guo,
Shuying Chen,
Shuang Liu,
Shouyun Li,
Haiyan Xing,
Qing Rao,
Jianxiang Wang,
and Min Wang
|
20121-20131 |
Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade |
https://doi.org/10.18632/oncotarget.3853
Ijeoma Adaku Umelo,
Olivier De Wever,
Peter Kronenberger,
Jan Van Deun,
Alfiah Noor,
Kshitiz Singh,
Erik Teugels,
Gang Chen,
Marc Bracke,
and Jacques De Grève
|
20132-20144 |
In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma |
https://doi.org/10.18632/oncotarget.3980
Jason K. Sa,
Yeup Yoon,
Misuk Kim,
Yeonghwan Kim,
Hee Jin Cho,
Jin-Ku Lee,
Gi-Soo Kim,
Suji Han,
Woon Jin Kim,
Yong Jae Shin,
Kyeung Min Joo,
Patrick J. Paddison,
Tohru Ishitani,
Jeongwu Lee,
and Do-Hyun Nam
|
20145-20159 |
Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development |
https://doi.org/10.18632/oncotarget.3969
Qingyang Gu,
Bin Zhang,
Hongye Sun,
Qiang Xu,
Yexiong Tan,
Guan Wang,
Qin Luo,
Weiguo Xu,
Shuqun Yang,
Jian Li,
Jing Fu,
Lei Chen,
Shengxian Yuan,
Guibai Liang,
Qunsheng Ji,
Shu-Hui Chen,
Chi-Chung Chan,
Weiping Zhou,
Xiaowei Xu,
Hongyang Wang,
and Douglas D. Fang
|
20160-20176 |
The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer
The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer |
https://doi.org/10.18632/oncotarget.3896
Cong Peng,
Xiaoting Jia,
Yan Xiong,
Jiang Yin,
Nan Li,
Yingen Deng,
Kai Luo,
Qiong Zhang,
Chengkun Wang,
Zhijie Zhang,
Guopei Zheng,
and Zhimin He
|
20177-20189 |
Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun
Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun |
https://doi.org/10.18632/oncotarget.4171
Dong-Hao Jin,
Jeeyun Lee,
Kyoung Mee Kim,
Sung Kim,
Duk-Hwan Kim,
and Joobae Park
|
20190-20203 |
High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder
High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder |
https://doi.org/10.18632/oncotarget.3887
Bo Wang,
Hao Liu,
Xiaoliang Dong,
Shaoxu Wu,
Hong Zeng,
Zhuowei Liu,
Di Wan,
Wen Dong,
Wang He,
Xu Chen,
Limin Zheng,
Jian Huang,
and Tianxin Lin
|
20204-20214 |
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro |
https://doi.org/10.18632/oncotarget.4046
Helen Künstlinger,
Jana Fassunke,
Hans-Ulrich Schildhaus,
Benedikt Brors,
Carina Heydt,
Michaela Angelika Ihle,
Gunhild Mechtersheimer,
Eva Wardelmann,
Reinhard Büttner,
and Sabine Merkelbach-Bruse
|
20215-20230 |
Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells
Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells |
https://doi.org/10.18632/oncotarget.4047
Seiichi Okabe,
Tetsuzo Tauchi,
Yuko Tanaka,
Juri Sakuta,
and Kazuma Ohyashiki
|
20231-20240 |
Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer
Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer |
https://doi.org/10.18632/oncotarget.4048
Pintong Huang,
Ying Zhang,
Jian Chen,
Weihui Shentu,
Yu Sun,
Zhijian Yang,
Tingbo Liang,
Shuyuan Chen,
and Zhaoxia Pu
|
20241-20251 |
BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis
BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis |
https://doi.org/10.18632/oncotarget.3857
Weilin Wang,
Pengfei Huang,
Panyisha Wu,
Rong Kong,
Jiang Xu,
Lufei Zhang,
Qifan Yang,
Qingsong Xie,
Linshi Zhang,
Xiaohu Zhou,
Linhui Chen,
Haiyang Xie,
Lin Zhou,
and Shusen Zheng
|
20252-20265 |
Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas
Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas |
https://doi.org/10.18632/oncotarget.4060
Ja Eun Kim,
Hye Rim Cho,
Wen Jun Xu,
Ji Young Kim,
Sung Kwon Kim,
Seung-Ki Kim,
Sung-Hye Park,
Hyeonjin Kim,
Se-Hoon Lee,
Seung Hong Choi,
Sunghyouk Park,
and Chul-Kee Park
|
20266-20277 |
Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining
Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining |
https://doi.org/10.18632/oncotarget.4275
Hongyan Huang,
Ang Chen,
Ting Wang,
Manna Wang,
Xiangkai Ning,
Meifang He,
Yazhuo Hu,
Long Yuan,
Shichong Li,
Qiwei Wang,
Hong Liu,
Zhaolie Chen,
Jun Ren,
and Qiang Sun
|
20278-20287 |
Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB
Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB |
https://doi.org/10.18632/oncotarget.3961
Kamila Müller-Edenborn,
Karolin Léger,
Jesus F. Glaus Garzon,
Carole Oertli,
Ali Mirsaidi,
Peter J. Richards,
Hubert Rehrauer,
Patrick Spielmann,
David Hoogewijs,
Lubor Borsig,
Michael O. Hottiger,
and Roland H. Wenger
|
20288-20301 |
The IgH 3’ regulatory region influences lymphomagenesis in Igλ-Myc mice
The IgH 3’ regulatory region influences lymphomagenesis in Igλ-Myc mice |
https://doi.org/10.18632/oncotarget.3963
Faten Saad,
Alexis Saintamand,
Michel Cogné,
and Yves Denizot
|
20302-20311 |
Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer
Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer |
https://doi.org/10.18632/oncotarget.3964
Chae Hwa Kwon,
Hye Ji Park,
Jin Hwa Choi,
Ja Rang Lee,
Hye Kyung Kim,
Hong-jae Jo,
Hyun Sung Kim,
Nahmgun Oh,
Geun Am Song,
and Do Youn Park
|
20312-20326 |
Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases
Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases |
https://doi.org/10.18632/oncotarget.3972
Naushad Ali,
Parthasarathy Chandrakesan,
Charles B. Nguyen,
Sanam Husain,
Allison F. Gillaspy,
Mark Huycke,
William L. Berry,
Randal May,
Dongfeng Qu,
Nathaniel Weygant,
Sripathi M. Sureban,
Michael S. Bronze,
Danny N. Dhanasekaran,
and Courtney W. Houchen
|
20327-20344 |
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4 |
https://doi.org/10.18632/oncotarget.3884
Wen Zhang,
Keli Ge,
Qian Zhao,
Xiufen Zhuang,
Zhenling Deng,
Lingling Liu,
Jie Li,
Yu Zhang,
Ying Dong,
Youhui Zhang,
Shuren Zhang,
and Binlei Liu
|
20345-20355 |
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability |
https://doi.org/10.18632/oncotarget.3931
Lan yu,
Zeng-Fu Shang,
Jian Wang,
Hongtao Wang,
Fang Huang,
Zhe Zhang,
Ying Wang,
Jianguang Zhou,
and Shanhu Li
|
20356-20369 |
Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge
Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge |
https://doi.org/10.18632/oncotarget.4827
Jaeyun Jung,
Chanjoo Yeom,
Yeon-Sook Choi,
Sinae Kim,
EunJi Lee,
Min Ji Park,
Sang Wook Kang,
Sung Bae Kim,
and Suhwan Chang
|
20370-20387 |
ROS1 amplification mediates resistance to gefitinib in glioblastoma cells
ROS1 amplification mediates resistance to gefitinib in glioblastoma cells |
https://doi.org/10.18632/oncotarget.3981
Hashim Aljohani,
Robert F. Koncar,
Ahmad Zarzour,
Byung Sun Park,
So Ha Lee,
and El Mustapha Bahassi
|
20388-20395 |
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers |
https://doi.org/10.18632/oncotarget.4056
Yihang Shen,
Yuan-Hao Lee,
Jayabal Panneerselvam,
Jun Zhang,
Lenora W. M. Loo,
and Peiwen Fei
|
20396-20403 |
Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma
Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma |
https://doi.org/10.18632/oncotarget.4057
Hao Bo,
Zhaojian Gong,
Wenling Zhang,
Xiayu Li,
Yong Zeng,
Qianjin Liao,
Pan Chen,
Lei Shi,
Yu Lian,
Yizhou Jing,
Ke Tang,
Zheng Li,
Yanhong Zhou,
Ming Zhou,
Bo Xiang,
Xiaoling Li,
Jianbo Yang,
Wei Xiong,
Guiyuan Li,
and Zhaoyang Zeng
|
20404-20418 |
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.3983
Ying Chen,
Zhanshan Cha,
Wenzheng Fang,
Baohua Qian,
Wenlong Yu,
Wenfeng Li,
Guanzhen Yu,
and Yong Gao
|
20419-20433 |
Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1
Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1 |
https://doi.org/10.18632/oncotarget.3886
Su Jin Hwang,
Hye Won Lee,
Hye Ree Kim,
Hye Jin Song,
Dong Heon Lee,
Hong Lee,
Chang Hoon Shin,
Je-Gun Joung,
Duk-Hwan Kim,
Kyeung Min Joo,
and Hyeon Ho Kim
|
20434-20448 |
Epigenetically downregulated Semaphorin 3E contributes to gastric cancer
Epigenetically downregulated Semaphorin 3E contributes to gastric cancer |
https://doi.org/10.18632/oncotarget.3936
Hui Chen,
Guo-Hua Xie,
Wei-Wei Wang,
Xiang-Liang Yuan,
Wen-Ming Xing,
Hong-Jing Liu,
Jin Chen,
Min Dou,
and Li-Song Shen
|
20449-20465 |
Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR
Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR |
https://doi.org/10.18632/oncotarget.4058
Eiji Iwama,
Koichi Takayama,
Taishi Harada,
Isamu Okamoto,
Fumihiko Ookubo,
Junji Kishimoto,
Eishi Baba,
Yoshinao Oda,
and Yoichi Nakanishi
|
20466-20473 |
Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression |
https://doi.org/10.18632/oncotarget.4105
Haolong Li,
Ning Xie,
Martin E. Gleave,
and Xuesen Dong
|
20474-20484 |
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis |
https://doi.org/10.18632/oncotarget.4107
Xiaorong Lin,
Lijun Chen,
Yandang Yao,
Ruihua Zhao,
Xiuying Cui,
Jun Chen,
Kailian Hou,
Mingxia Zhang,
Fengxi Su,
Jingqi Chen,
and Erwei Song
|
20485-20499 |
Tumorigenesis and peritoneal colonization from fallopian tube epithelium
Tumorigenesis and peritoneal colonization from fallopian tube epithelium |
https://doi.org/10.18632/oncotarget.3985
Sharon L. Eddie,
Suzanne M. Quartuccio,
Eoghainin Ó hAinmhire,
Georgette Moyle-Heyrman,
Dan D. Lantvit,
Jian-Jun Wei,
Barbara C. Vanderhyden,
and Joanna E. Burdette
|
20500-20512 |
An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells
An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells |
https://doi.org/10.18632/oncotarget.4109
Wei-Hsin Chiu,
Wu-Chou Su,
Chia-Ling Li,
Chia-Ling Chen,
and Chiou-Feng Lin
|
20513-20524 |
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition |
https://doi.org/10.18632/oncotarget.3890
Matthew L. Fisher,
Gautam Adhikary,
Wen Xu,
Candace Kerr,
Jeffrey W. Keillor,
and Richard L. Eckert
|
20525-20539 |
Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth
Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth |
https://doi.org/10.18632/oncotarget.4110
Ying Shi,
Guo-Bin Chen,
Xiao-Xiao Huang,
Chuan-Xing Xiao,
Huan-Huan Wang,
Ye-Sen Li,
Jin-Fang Zhang,
Shao Li,
Yin Xia,
Jian-Lin Ren,
and Bayasi Guleng
|
20540-20554 |
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
https://doi.org/10.18632/oncotarget.4111
Nina A. Sibbesen,
Katharina L. Kopp,
Ivan V. Litvinov,
Lars Jønson,
Andreas Willerslev-Olsen,
Simon Fredholm,
David L. Petersen,
Claudia Nastasi,
Thorbjørn Krejsgaard,
Lise M. Lindahl,
Robert Gniadecki,
Nigel P. Mongan,
Denis Sasseville,
Mariusz A. Wasik,
Lars Iversen,
Charlotte M. Bonefeld,
Carsten Geisler,
Anders Woetmann,
and Niels Odum
|
20555-20569 |
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells |
https://doi.org/10.18632/oncotarget.4135
Alastair H. Davies,
Kristen Reipas,
Kaiji Hu,
Rachel Berns,
Natalie Firmino,
Anna L. Stratford,
and Sandra E. Dunn
|
20570-20577 |
Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents
Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents |
https://doi.org/10.18632/oncotarget.3987
Chenchu Lin,
Hanlin Zeng,
Junyan Lu,
Zuoquan Xie,
Wenyi Sun,
Cheng Luo,
Jian Ding,
Shengtao Yuan,
Meiyu Geng,
and Min Huang
|
20578-20591 |
Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer |
https://doi.org/10.18632/oncotarget.4112
Benling Xu,
Long Yuan,
Quanli Gao,
Peng Yuan,
Peng Zhao,
Huijuan Yuan,
Huijie Fan,
Tiepeng Li,
Peng Qin,
Lu Han,
Weijia Fang,
and Zhenhe Suo
|
20592-20603 |
The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer |
https://doi.org/10.18632/oncotarget.3774
Debashish Sahay,
Raphael Leblanc,
Thomas G.P. Grunewald,
Srikant Ambatipudi,
Johnny Ribeiro,
Philippe Clézardin,
and Olivier Peyruchaud
|
20604-20620 |
Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 - implications for a combinatorial treatment
Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 - implications for a combinatorial treatment |
https://doi.org/10.18632/oncotarget.4139
Charlotte Fristedt Duvefelt,
Susanne Lub,
Prasoon Agarwal,
Linda Arngården,
Anna Hammarberg,
Ken Maes,
Els Van Valckenborgh,
Karin Vanderkerken,
and Helena Jernberg Wiklund
|
20621-20635 |
Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells
Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells |
https://doi.org/10.18632/oncotarget.4114
Junyun Wang,
Nan Ding,
Yongjun Li,
Hua Cheng,
Dong Wang,
Qiong Yang,
Youhui Deng,
Yaran Yang,
Yanming Li,
Xiuyan Ruan,
Fang Xie,
Hua Zhao,
and Xiangdong Fang
|
20636-20649 |
Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth
Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth |
https://doi.org/10.18632/oncotarget.4115
Ying Liu,
Shifang Ren,
Liqi Xie,
Chunhong Cui,
Yang Xing,
Chanjuan Liu,
Benjin Cao,
Fan Yang,
Yinan Li,
Xiaoning Chen,
Yuanyan Wei,
Haojie Lu,
and Jianhai Jiang
|
20650-20660 |
RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma
RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma |
https://doi.org/10.18632/oncotarget.3861
Xing Gu,
Bin Li,
Mingming Jiang,
Meng Fang,
Jun Ji,
Aihua Wang,
Mengmeng Wang,
Xiaoqing Jiang,
and Chunfang Gao
|
20661-20671 |
Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma
Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma |
https://doi.org/10.18632/oncotarget.3967
Zhiyong Shen,
Haijun Deng,
Yuan Fang,
Xianjun Zhu,
Geng-tai Ye,
Li Yan,
Hao Liu,
and Guoxin Li
|
20672-20684 |
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.3930
Longhua Sun,
Lihong Bai,
Gengpeng Lin,
Rang Wang,
Yangli Liu,
Jinghuang Cai,
Yubiao Guo,
Zhiwen Zhu,
and Canmao Xie
|
20685-20696 |
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis |
https://doi.org/10.18632/oncotarget.4136
Jino Park,
Michaela Schlederer,
Martin Schreiber,
Ryan Ice,
Olaf Merkel,
Martin Bilban,
Sebastian Hofbauer,
Soojin Kim,
Joseph Addison,
Jie Zou,
Chunyan Ji,
Silvia T. Bunting,
Zhengqi Wang,
Menachem Shoham,
Gang Huang,
Zsuzsanna Bago-Horvath,
Laura F. Gibson,
Yon Rojanasakul,
Scot Remick,
Alexey Ivanov,
Elena Pugacheva,
Kevin D. Bunting,
Richard Moriggl,
Lukas Kenner,
and William Tse
|
20697-20710 |
SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth
SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth |
https://doi.org/10.18632/oncotarget.4133
Hai-yan Wang,
Ping Lian,
and Peng-Sheng Zheng
|
20711-20722 |
Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)
Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP) |
https://doi.org/10.18632/oncotarget.3978
Nikki A. Evensen,
Yiyi Li,
Cem Kuscu,
Jingxuan Liu,
Jillian Cathcart,
Anna Banach,
Qian Zhang,
Ellen Li,
Sonia Joshi,
Jie Yang,
Paula I. Denoya,
Silvia Pastorekova,
Stanley Zucker,
Kenneth R. Shroyer,
and Jian Cao
|
20723-20739 |